Diabetes Navigator

Clinical tools · CDMtools
Loading...
📖 Reference →
Clinical decision support — not a prescribing tool. This calculator applies standard titration rules (NICE NG28, TITRATE study) and presents the underpinning principle. All dose adjustments remain at the clinician's discretion.
Basal insulin titration — 3-3-3 rule
Fasting CBG — last 3 consecutive days (mmol/L)
Clinical decision remains with the prescribing clinician. Consider full clinical context: recent illness, dietary change, renal function, concomitant medications, patient concordance, and monitoring capability before any dose adjustment.
Bolus dose calculation — MDI / correction factor
Clinical decision remains with the prescribing clinician. Carb counting accuracy, glycaemic variability, and patient-specific factors must be considered. DAFNE-trained patients should apply their individual ratios.
Dose reduction — hypoglycaemia or over-treatment
Clinical decision remains with the prescribing clinician. Consider whether the hypo was provoked (missed meal, unusual exertion) vs unprovoked before reducing dose. De-escalation in frailty should involve patient, carer, and diabetes team.

DVLA — Diabetes and Driving

Fitness to drive guidance for patients treated with insulin or insulin secretagogues. All decisions must be assessed against current DVLA At a Glance guidance.

Open DVLA At a Glance guidance Patient information — Diabetes & Driving (PDF)
DVLA guidance updates regularly. Always verify against the current edition of "At a Glance Guide to the Current Medical Standards of Fitness to Drive" (DVLA). This summary is for clinician reference only.
TreatmentLicence typeDVLA notification?Action
Diet only / metformin / DPP-4i / SGLT2i / GLP-1 RA (no hypo risk) Group 1 & Group 2 Not required Annual review. No driving restriction.
Sulphonylurea (gliclazide, glimepiride) or meglitinide Group 1 Notify DVLA Complete D1/D4 form. CBG ≥ 5.0 mmol/L before driving. Annual DVLA review.
Sulphonylurea or meglitinide Group 2 (HGV/bus) Must notify DVLA Individual assessment. Strict CBG monitoring required.
Insulin (all types) Group 1 Must notify DVLA Complete DIAB1. Must satisfy all monitoring and hypo awareness criteria.
Insulin Group 2 (HGV/bus) Must notify DVLA Much stricter criteria apply — see below. Most patients cannot hold Group 2 on insulin.
Requirements to drive
  • Check CBG ≥ 45 minutes before driving
  • CBG must be ≥ 5.0 mmol/L before starting journey
  • Recheck CBG every 2 hours on long journeys
  • Fast-acting glucose must be accessible in vehicle (not in boot)
  • Do not drive if CBG < 4.0 mmol/L — treat and wait 45 min before reassessing
  • Must have adequate hypoglycaemia awareness
  • Must not have had a severe hypoglycaemic episode whilst driving in the last 12 months
  • Complete DVLA DIAB1 form and carry medical ID
Revocation / refusal triggers (Group 1)
  • Two or more episodes of hypoglycaemia requiring assistance in last 12 months
  • Severe hypo whilst driving
  • Impaired hypoglycaemia awareness (unawareness)
  • CBG consistently < 5.0 mmol/L pre-drive and unable to correct
  • Inability to comply with CBG monitoring requirements
Group 1 licence may be re-licensed after 3 months if hypo awareness restored and no further episodes.
Group 2 entitlement on insulin is exceptional — most patients will not qualify. The standard position is that insulin-treated patients may not hold a Group 2 licence. Individual DVLA assessment required.

To be considered for Group 2 entitlement, an insulin-treated patient must satisfy all of the following:

  • No episode of disabling hypoglycaemia in the preceding 12 months
  • Full hypoglycaemia awareness
  • CBG monitoring at least twice daily and at relevant times (pre-drive, every 2 hours)
  • CBG ≥ 5.0 mmol/L before each driving period and after each 2-hour interval
  • Ability to recognise and treat hypoglycaemia
  • A consistent pattern of glucose control without severe excursions
  • Annual independent medical examination by an endocrinologist / diabetologist

Use of CGM with low glucose alarm is strongly recommended but does not remove manual CBG requirement.

When to suspect unawareness
Symptomatic hypo only when CBG < 3.0 mmol/L · Adrenergic symptoms absent · Prolonged T1DM duration · Frequent nocturnal hypos · Autonomic neuropathy · Beta-blocker use
Clinical obligations
Advise to stop driving immediately
Refer to diabetes specialist or structured education (BGAT, HARPdoc)
Avoid CBG < 4.0 for minimum 3 months to restore awareness
Reassess awareness before re-licensing
CGM / FreeStyle Libre
CGM does not replace CBG requirement for DVLA purposes. Real-time CGM with low-glucose alert recommended as adjunct. Driving still requires manual CBG ≥ 5.0 mmol/L before starting. A declining CGM trend below 5.0 should trigger same response as a low reading.
GP documentation
Document DVLA advice in every consultation where insulin or SU started or dose changed · Record patient's confirmation they have notified DVLA · If patient refuses to notify and continues driving: consider GMC duty to disclose guidance (Confidentiality: patients' fitness to drive)
FormPurposeCompleted by
DIAB1Insulin-treated diabetes — Group 1 notificationPatient (DVLA processes)
DIAB1AInsulin-treated diabetes — Group 2 (HGV) notificationPatient + specialist
D1 / D4Sulphonylurea or other hypo-risk oral agent — Group 1Patient
Specialist report (INF240)Consultant report for borderline / contested casesEndocrinologist / diabetologist
Patient information leaflet — Diabetes & DrivingPatient information leaflet — diabetes and drivingProvide to patient at insulin start / SU start
🔷
PRISM
Diabetes Scorecard
PREVIEW v1.0
Primary care Review and Intervention Scorecard for Multimorbidity
Inspired by the Balanced Scorecard framework (Kaplan & Norton, 1992) — adapted for structured clinical review in NHS primary care. PRISM translates the multi-domain performance review concept into a patient-level clinical decision support tool, mapping evidence-based guideline targets across six clinical domains to generate an actionable review summary and patient-facing output.  ·  © Gupta R, Gupta A (2026) · CDMtools
Enter values across all six domains. PRISM checks each against NICE guidelines / individualised targets and generates a shareable scorecard summary. No patient-identifiable data is stored.

Patient Profile

Clinician identity is captured automatically from your login — no initials needed. No patient-identifiable data is stored.

Patient cohort — drives HbA1c target & NG28 therapy alignment

Cardiovascular & frailty
Diabetes history
Duration >15y with QRISK3 ≥10% (entered under Lipids) is treated as CV-risk-equivalent for statin intensity and NG28 — not the same as confirmed ASCVD. Diagnosed before 40 feeds NG28 therapy alignment.
HbA1c target: any frailty grade, ASCVD, the duration toggle, age >75, or palliative each widen it — most relaxed wins if more than one applies. On sulfonylurea/insulin below widens it too if nothing here is more relevant. Standard target (≤48) applies if none of this does.
Current therapy
Body measurements

1 — HbA1c

Not entered
Leave blank if unavailable / first result

2 — Lipids / statin management

Not entered
Statin status
Enter from EMIS/SystmOne, or calculate on the QRISK & Drugs tab and come back.
Lipid panel
Or enter TC and HDL — auto-calculated

3 — Blood pressure

Not entered
Past medical history — BP / cardiovascular
NICE NG136 / NG28: Clinic BP ≥ 140/90 should be confirmed with home BP monitoring (HBPM) or ABPM before diagnosing hypertension and initiating treatment — unless BP is severely elevated (≥ 180/120) or end-organ damage is present. HBPM target: average ≥ 135/85 mmHg confirms hypertension.  CDMtools HT Diagnostic Tool ↗
Antihypertensive medications prescribed

4 — CKD / renal

Not entered
CKD diagnosis requires persistence (NICE CG182): eGFR < 60 or ACR ≥ 3 mg/mmol must be confirmed on two separate readings at least 90 days apart before coding CKD. A single abnormal result may represent AKI, dehydration, or a transient cause. Do not code CKD or initiate long-term management changes on a single result alone.
Past medical history — renal
Captured in Patient Profile above ("On SGLT2i?")

5 — Foot risk / complications screening

Not entered
Diabetic neuropathy

6 — Liver / MASLD screening

Not entered
~70% of T2DM patients have metabolic-associated steatotic liver disease (MASLD, formerly NAFLD). Most are undiagnosed. FIB-4 is the recommended first-line triage tool (NHS England MASLD pathway 2023 · BSG/BLT primary care guidance 2023). NICE NG49 under review — expected to formalise FIB-4 as first-line step.
Past medical history — liver / metabolic
Upper limit of normal ~40 U/L (lab-dependent)
ULN ~55 U/L (M) / ~35 U/L (F)
Required for FIB-4 calculation
FIB-4 = (age × AST) ÷ (platelets × √ALT). Requires age in Review Settings.
🔬 Full MASLD pathway assessment coming to CDMtools FIB-4 · ELF · Fibroscan · EASL 2024 pathway · MASLD Navigator
Diabetes Review Scorecard
CDMtools · For registered healthcare professionals
ℹ️ Print scorecard for a local clinical record copy. Use the clinician letter button below for a formatted summary with findings, recommendations, and guideline references.
Clinician letter — formatted clinical summary with domain findings, NICE-referenced recommendations, monitoring plan, and copy-to-clipboard for EMIS / SystmOne.
Patient link / QR opens a clean summary page (cdmtools.co.uk/patient-summary/) — no clinical navigator UI, no username in the URL. Safe to share directly with patients.
Complete review — tick actions taken, select review interval, generate patient letter with Ref number.
⚠ This scorecard contains no patient-identifiable information. It is a clinical decision support summary for use by registered healthcare professionals. All data is encoded in the URL — nothing is stored on CDMtools servers. Clinical decisions remain with the treating clinician.
PRISM Diabetes Scorecard · © Gupta R, Gupta A (2026) · NICE NG28 / NG238

🏥 Sick Day Rules — Patient Card Generator

Choose a mode: Bespoke — tick the patient's actual medications to generate a personalised card. Standard — select a pre-set rule set for common combinations. Print the card to give to the patient.

Tick all medications this patient takes
☝ Tick the patient's medications above — a personalised sick day card will appear instantly below.

Sick Day Rules — If you use INSULIN

Keep this information safe. Share it with your family or carers.

🚫
NEVER stop your insulin when you are unwell

Even if you cannot eat, your body needs insulin. Stopping insulin causes dangerous ketones to build up in your blood — this can lead to DKA (diabetic ketoacidosis), which is a medical emergency.

📊
Check your blood glucose every 2–4 hours when unwell

Check for ketones if blood glucose above 14 mmol/L — use blood ketone meter (preferred) or urine ketone sticks if unavailable.

💧
Drink at least 2.5 litres (4 pints) of sugar-free fluids per day

Sip regularly — even small amounts if feeling sick. If you cannot keep fluids down: call 999.

Blood glucose readingWhat to do
< 4.0 mmol/LTreat hypo: 15–20 g fast glucose (4–5 glucose tabs). Recheck in 15 min. Do not drive.
4.0–7.0 mmol/LIn target. Continue usual insulin. Eat if able. Monitor 2–4 hourly.
7.1–14.0 mmol/LAbove target. Stay hydrated. Check ketones. Contact your GP or diabetes team if no improvement.
> 14.0 mmol/LCheck ketones immediately. Blood ketones ≥ 0.6 mmol/L (or urine 1+): contact GP urgently. Blood ketones ≥ 1.5 mmol/L: go to A&E.
🚨
Call 999 or go to A&E immediately if:

You are vomiting repeatedly and cannot keep fluids down · Blood ketones ≥ 3.0 mmol/L (or urine 3+) · You feel very confused, drowsy, or cannot be roused · Blood glucose consistently > 17 mmol/L despite extra insulin

🎒
Keep these at home

Glucose tablets · Glucagon emergency kit (GlucaGen / Baqsimi) · Ketone testing strips · Spare insulin pen + needles · Written copy of these sick day rules

Your GP practice: —
Phone: —
Out of hours: Call NHS 24 (111) or 999 in emergency
© Gupta R, Gupta A (2026) · CDMtools · TREND-UK · NICE NG17 / NG28 · JBDS-IP · For use under clinical supervision

Sick Day Rules — If you take an SGLT2 inhibitor

Dapagliflozin (Forxiga) · Empagliflozin (Jardiance) · Canagliflozin (Invokana)

⚠️
STOP your SGLT2 inhibitor tablet if any of the following apply

You are vomiting or have severe diarrhoea · You cannot eat or drink normally · You are fasting for surgery or a medical procedure · You have a serious infection or fever · You feel very unwell

✅
When to restart

You can restart your SGLT2 inhibitor tablet when you have been eating and drinking normally for at least 24–48 hours and you feel well again. If unsure — contact your GP or pharmacist.

🔬
Why this matters — DKA risk (euglycaemic DKA)

SGLT2 inhibitors can cause a rare but dangerous condition called euglycaemic DKA. Unlike normal DKA, your blood glucose may be normal or only mildly raised — so you might not realise how unwell you are. Symptoms: nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing.

🚨
Seek urgent help if you have stopped the tablet but still develop:

Nausea or vomiting · Abdominal pain · Rapid breathing or shortness of breath · Unusual tiredness · Fruity-smelling breath · These symptoms need urgent blood ketone testing and medical review.

SituationAction
Vomiting / diarrhoeaStop SGLT2i immediately. Stay hydrated. Monitor glucose.
Planned surgery / procedureStop SGLT2i at least 3 days before (some guidance says up to 5 days for major surgery).
Reduced oral intakeStop SGLT2i if unable to eat normally.
Symptoms of DKA despite normal glucoseA&E immediately — request blood ketone measurement.
Your GP practice: —
Phone: —
Out of hours: Call NHS 24 (111) or 999 in emergency
© Gupta R, Gupta A (2026) · CDMtools · ABCD / TREND-UK · NICE NG28 · For use under clinical supervision
Combined rules for patients on both insulin and an SGLT2 inhibitor. Both rule sets apply — SGLT2i is stopped when unwell; insulin is continued.

Sick Day Rules — Insulin + SGLT2 inhibitor

You take both insulin injections AND an SGLT2 inhibitor tablet. Different rules apply to each.

💉
NEVER stop your insulin

Even when unwell and not eating — always take your insulin. Your body needs it.

💊
STOP your SGLT2 inhibitor tablet if you are vomiting, have diarrhoea, cannot eat, or feel very unwell

Restart only when eating and drinking normally for 24–48 hours.

📊
Check blood glucose every 2–4 hours. Check ketones if glucose > 14 mmol/L.

With SGLT2i: DKA can occur with near-normal glucose levels — don't be falsely reassured.

🚨
Go to A&E immediately if:

Vomiting repeatedly · Blood ketones ≥ 0.6 mmol/L (or urine 1+) (even with normal glucose) · Confusion or drowsiness · Unable to keep fluids down

Your GP practice: —
Phone: —
Out of hours: Call NHS 24 (111) or 999 in emergency
© Gupta R, Gupta A (2026) · CDMtools · TREND-UK · ABCD · NICE NG28 · For use under clinical supervision

Sick Day Rules — ACE inhibitor, ARB & diuretic

Ramipril · Lisinopril · Losartan · Candesartan · Furosemide · Indapamide · Bendroflumethiazide

⚠️
STOP your ACE inhibitor / ARB AND your diuretic ("water tablet") if you become unwell

When you are unwell, dehydrated, vomiting, or have diarrhoea, these medicines together can cause sudden kidney injury. This is sometimes called the "triple whammy" if you are also taking ibuprofen or other anti-inflammatory tablets.

✅
When to restart

Restart all your usual medicines when you have been eating and drinking normally for 24–48 hours and feel well again. If unsure — contact your GP or pharmacist before restarting.

🚫
Avoid ibuprofen, naproxen, or other anti-inflammatory painkillers when unwell

These tablets (NSAIDs) put extra strain on the kidneys when combined with your BP medicines. Use paracetamol instead for pain or fever when unwell.

SituationAction
Vomiting or diarrhoeaStop ACEi/ARB and diuretic. Keep hydrated with water/clear fluids. Restart when well for 48h.
Cannot eat or drinkStop ACEi/ARB and diuretic. Seek medical advice if lasting > 24h.
Prescribed antibiotics or antifungalsSome antibiotics can interact — check with GP or pharmacist whether to pause BP medicines.
Planned surgery or procedureTell your surgeon you take these medicines. You may be asked to stop them 24–48h before.
Signs of kidney problems: passing very little or no urine, swollen legs, confusionSeek urgent medical advice — call your GP or NHS 24 (111).
💧
Keep well hydrated at all times

Aim for 6–8 glasses of fluid per day. Staying hydrated is the single most important thing you can do to protect your kidneys when you are also taking these medicines.

Your GP practice: —
Phone: —
Out of hours: Call NHS 24 (111) or 999 in emergency
CDMtools · SynaptAI Limited · Evidence: MHRA drug safety update · NICE NG28 · For use under clinical supervision
🧮
QRISK3 Cardiovascular Risk Calculator
QRISK3 is the recommended cardiovascular risk tool in NICE NG28 and NG238. Calculate 10-year CVD risk to guide statin prescribing in diabetes. Enter the result in Domain 2 (Lipids) of the PRISM scorecard.
Open QRISK3 Calculator ↗
When to calculate QRISK3 in diabetes
✓ Statin indicated if QRISK3 ≥ 10% — offer high-intensity statin (NICE NG238)
ℹ T1DM: consider statin if age ≥ 40 or DM duration ≥ 10 years regardless of score
ℹ T2DM: all patients should have QRISK3 calculated at diagnosis and reviewed annually
⚠ Secondary prevention: statin regardless of QRISK3 score — do not calculate
⚗️
Diabetes Drug Interaction Checker
Select all drug classes in use — clinically significant interactions are flagged automatically. Focused on diabetes pharmacology. Not exhaustive — always verify with BNF for complete review.
Select drug classes above to check interactions.
✓ Thanks — feedback received
★ ★ ★ ★ ★
Select a star rating above to submit
✓ Thanks — feedback received